L. Liebes

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

The possible role of the kynurenine pathway in adolescent depression with melancholic features.

J. Babb, R. Klein, V. Gabbay, 2010, Journal of child psychology and psychiatry, and allied disciplines.

Purification and Characterization of Actin from Normal and Chronic Lymphocytic Leukemia Lymphocytes 1

R. Silber, L. Liebes, G. Grusky, 2006 .

Biologic Activity of Interleukin 1 (IL‐1) Alpha in Patients with Refractory Malignancies

D. Peace, M. Rosenthal, A. Chachoua, 1998, Journal of immunotherapy.

Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity in CLL B lymphocytes

R. Silber, L. Liebes, C. Farber, 1989, British journal of haematology.

Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.

R. Silber, B. Bank, L. Liebes, 1989, Cancer research.

A reappraisal of leukocyte dehydroascorbate reductase.

R. Silber, L. Liebes, R. Stahl, 1985, Biochimica et biophysica acta.

Purification and characterization of actin from normal and chronic lymphocytic leukemia lymphocytes.

R. Silber, L. Liebes, G. Grusky, 1983, Cancer research.

Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia.

R. Silber, M. Conklyn, L. Liebes, 1982, Blood.

A specific high-performance liquid chromatography assay for dehydroascorbic acid shows an increased content in CLL lymphocytes.

R. Silber, L. Liebes, S. Kanengiser, 1983, Analytical biochemistry.

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients

D. Polsky, H. Yee, I. Osman, 2008, Journal of Translational Medicine.

Increase in circulating bone marrow progenitor cells after myocardial infarction

D. Spevack, I. Kronzon, G. Inghirami, 2006, Coronary artery disease.

Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.

A. Zeleniuch‐Jacquotte, H. Hochster, M. Potměšil, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

9‐Aminocamptothecin and Beyond

S. Arbuck, C. Takimoto, H. Hochster, 1996, Annals of the New York Academy of Sciences.

Oral Presentations—Abstracts

A. Eggermont, K. Edwards, A. Chanan-Khan, 2003, Turkish Journal of Biochemistry.

Combining aminocyanine dyes with polyamide dendrons: a promising strategy for imaging in the near-infrared region.

M. Weck, C. Ornelas, J. Canary, 2011, Chemistry.

Identification and quantitation of ascorbic acid in extracts of human lymphocytes by high-performance liquid chromatography.

E. Pelle, R. Silber, L. Liebes, 1981, Analytical biochemistry.

[2] Glutathione dehydrogenase (ascorbate)

R. Silber, L. Liebes, R. Stahl, 1986 .

A spectrophotometric assay for dehydroascorbate reductase.

R. Silber, L. Liebes, C. Farber, 1983, Analytical biochemistry.

Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia.

R. Silber, L. Liebes, C. Farber, 1985, Cancer research.

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.

F M Muggia, J Szebeni, A. Chanan-Khan, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.

M. Schwartz, L. Liebes, A. Goldenberg, 2005, The oncologist.

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations

M. Pincus, W. Gerald, I. Osman, 2008, Oncogene.

Bortezomib: Understanding the Mechanism of Action

R. Perez-soler, Y. Ling, F. Muggia, 2011, Molecular Cancer Therapeutics.

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.

Helen X. Chen, J. Sparano, C. Runowicz, 2010, Gynecologic oncology.

Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

S. Demaria, S. Adams, L. Chiriboga, 2012, Clinical Cancer Research.

Phase I Clinical and Pharmacokinetic Study of BMS-247550, a Novel Derivative of Epothilone B, in Solid Tumors

Susan Band Horwitz, Anne Hamilton, D. Lebwohl, 2004, Clinical Cancer Research.

Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs.

P. Furmanski, J. Bezault, H. Frost, 1993, In vivo.

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

P. Elliott, R. Perez-soler, Jian-Dong Jiang, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

N. Kawashima, S. Demaria, S. Formenti, 2004, International journal of radiation oncology, biology, physics.

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

J. Sparano, Mimi Kim, S. Blank, 2020, Cancer Chemotherapy and Pharmacology.

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

P. Ott, A. Pavlick, Y. Shao, 2012, Cancer Chemotherapy and Pharmacology.

Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes.

R. Silber, M. Conklyn, L. Liebes, 1983, Cancer research.

Continuous-flow scanning of selected high-performance liquid chromatography peak components by microprocessor control. Application to analysis of extracts from human lymphocytes.

L. Liebes, 1981, Journal of chromatography.

Insulin-like Growth Factor Binding Protein-4 Differentially Inhibits Growth Factor-induced Angiogenesis*

C. Rosen, R. Friesel, A. Akalu, 2011, The Journal of Biological Chemistry.

Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.

R. Ceriani, S. Denardo, S. Glenn, 1994, Advances in experimental medicine and biology.

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

D. Polsky, H. Yee, P. Ott, 2010, PloS one.

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.

R. Ceriani, P. Furmanski, H. Hochster, 2001, Cancer research.

Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.

Longgui Wang, J. Melamed, J. Babb, 2008, Cancer research.

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

Xue-Ru Wu, Luis Chiriboga, D. Bajorin, 2007, Journal of Translational Medicine.

Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer

Sang Lee, Anne Hamilton, H. Yee, 2005, Clinical Cancer Research.

Topical TLR 7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

S. Demaria, S. Adams, L. Chiriboga, 2012 .

Monocyte Activation Following Systemic Administration of Granulocyte‐Macrophage Colony‐Stimulating Factor

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Bortezomib with Taxanes

R. Perez-soler, Y. Ling, L. Liebes, 2004 .

Survival of advanced melanoma patients with normal LDH treated with oblimersen, temozolomide, and nab-paclitaxel.

H. Yee, P. Ott, A. Pavlick, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin.

P. Brooks, A. Akalu, L. Liebes, 2007, Cancer research.

Epitope in Laminin Targeting a Matrix Immobilized Cryptic Extracellular Matrix Inhibition of Angiogenesis and Tumor Metastasis

P. Brooks, A. Akalu, L. Liebes, 2007 .

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): A phase I study with pharmacology

H. Hochster, F. Muggia, L. Liebes, 2008, Cancer Chemotherapy and Pharmacology.

Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes.

R. Silber, L. Liebes, C. Farber, 1984, Journal of immunology.

Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report.

U. Beller, M. Dugan, A. Chachoua, 1989 .

Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer

H. Weiner, J. Finlay, S. Gardner, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Recombinant (cid:2) 2(IV)NC1 Domain Inhibits Tumor Cell-Extracellular Matrix Interactions, Induces Cellular Senescence, and Inhibits Tumor Growth in Vivo

S. Formenti, P. Brooks, S. MacDonald, 2005 .

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.

D. Alberts, E. Trimble, R. Ozols, 2006, Gynecologic oncology.

The anomalous capping behavior of chronic lymphocytic leukemia lymphocytes: studies with an antilymphocyte antiserum.

R. Silber, L. Liebes, F. Quagliata, 1978, Clinical immunology and immunopathology.

The possible role of the kynurenine pathway in anhedonia in adolescents

Benjamin A. Ely, J. Babb, V. Gabbay, 2012, Journal of Neural Transmission.

Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study.

G. Denardo, S. Denardo, S. Glenn, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients

M. Mazumdar, D. Polsky, D. Bajorin, 2008, Clinical Cancer Research.

BAY 43-9006 (sorafenib-BAY) alters proliferation pathways and mutant specific-PCR (MS-PCR) improves detection of BRAF mutations in metastatic melanoma (MM)

D. Polsky, H. Yee, I. Osman, 2007 .

Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis

S. Formenti, P. Brooks, P. Gagne, 2007, Clinical Cancer Research.

Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes.

M. Shelanski, R. Silber, L. Liebes, 1984, Blood.

Open access, freely available online PLoS BIOLOGY Intravital Observation of Plasmodium berghei Sporozoite Infection of the Liver

H. Yee, K. Matuschewski, U. Frevert, 2022 .

Construction of a well-defined multifunctional dendrimer for theranostics.

Marcus Weck, M. Weck, C. Ornelas, 2011, Organic letters.

Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytes.

E. Pelle, R. Silber, L. Liebes, 1981, Proceedings of the National Academy of Sciences of the United States of America.

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor

A. Pavlick, H. Hochster, F. Muggia, 2004, Anti-cancer drugs.

The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study

J. Babb, O. Gonen, Songtao Liu, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES

F M Muggia, J Szebeni, A. Chanan-Khan, 2002, Journal of liposome research.

Phase I Trial of Escalating Dose Doxorubicin Administered Concurrently with α2-Interferon

H. Hochster, Michael D. Green, F. Muggia, 1988 .

ROS Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib , a Novel Proteasome Inhibitor , in Human H 460 Non-Small Cell Lung Cancer Cells

R. Perez-soler, Y. Zou, Y. Ling, 2003 .

Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.

S. Formenti, P. Brooks, S. MacDonald, 2005, The American journal of pathology.

Continuous-infusion topotecan and erlotinib: a study in topotecan-pretreated ovarian cancer assessing shed collagen epitopes as a marker of invasiveness.

E. Warner, F. Muggia, B. Levinson, 2014, The oncologist.

Pegylated liposomal doxorubicin (PLD) with bevacizumab (B) in second-line treatment of ovarian cancer (OC): Pharmacokinetics (PK), safety, and preliminary outcome results.

C. Muller, C. Verschraegen, S. Blank, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of sorafenib (S [BAY 43–9006]) in metastatic melanoma (MM) including detection of BRAF with mutant specific-PCR (MS-PCR) and altered proliferation pathways-final outcome analysis

D. Polsky, H. Yee, I. Osman, 2008 .

Phase IB study of low‐dose intraperitoneal recombinant interleukin‐2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report

U. Beller, M. Dugan, A. Chachoua, 1990, Gynecologic oncology.

Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.

C. Pettinelli, S. Spector, D. Dieterich, 1990, Annals of internal medicine.

Investigation of the Influence of Particle Size on the Productivity of Preparative HPLC Columns

G. Guiochon, H. Colin, L. Liebes, 1987, Preparative-Scale Chromatography.

The quantitation of actin in human lymphocytes by isoelectric focusing.

R. Silber, L. Liebes, R. Stark, 1982, Biochemical medicine.

The solution behavior of the bovine myelin basic protein in the presence of anionic ligands. Binding behavior with the red component of trypan blue and sodium dodecyl sulfate.

W. D. Phillips, L. Liebes, R. Zand, 1976, Biochimica et biophysica acta.

Combining aminocyanine dyes with polyamide dendrons: a promising strategy for imaging in the near-infrared region.

M. Weck, C. Ornelas, J. Canary, 2011, Chemistry.

Solution behavior, circular dichroism and 22 HMz PMR studies of the bovine myelin basic protein.

W. D. Phillips, L. Liebes, R. Zand, 1975, Biochimica et biophysica acta.

A phase II trial of BAY 43-9006 in metastatic melanoma with molecularly characterized B-Raf status.

D. Polsky, I. Osman, A. Pavlick, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacodynamics/pharmacokinetics of intragastric camptothecin analogs in a human-cancer xenograft model

B. Giovanella, M. Wani, M. Wall, 1995 .

Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression.

M. Schwartz, L. Liebes, A. Goldenberg, 2005, The oncologist.

Efficacy and toxicity of concurrent rituximab plus infusional EPOCH in HIV-associated lymphoma: AIDS Malignancy Consortium Trial 034

J. Sparano, A. Levine, L. Liebes, 2008 .

A phase I/II study to determine the feasibility and efficacy of the triple combination of oblimersen (OBL), abraxane (ABX), and temozolomide (TMZ) in metastatic melanoma and normal LDH

T. Ryan, H. Yee, A. Pavlick, 2008 .

Journal of Translational Medicine the Histone Deacetylase Inhibitor Belinostat (pxd101) Suppresses Bladder Cancer Cell Growth in Vitro and in Vivo

D. Bajorin, T. Sun, L. Chiriboga, 2022 .